Gainers Neuronetics (NASDAQ:STIM) shares moved upwards by 34.1% to $2.91 during Tuesday's regul

LEXINGTON, Mass., July 30, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company

On Wednesday, Curis Inc. (NASDAQ:CRIS) announced updated positive clinical trial results for its inv

Curis gained attention after positive emavusertib data as analyst raised its price target to $43 and

HC Wainwright & Co. analyst Sara Nik maintains Curis (NASDAQ:CRIS) with a Buy and raises the

Curis, Inc. (CRIS) Discusses Positive Data From Emavusertib Combination Study in Primary CNS Lymphom

Curis Inc. (NASDAQ:CRIS) on Wednesday announced updated positive clinical trial results for its inve

Curis shares positive updated clinical data for emavusertib and increases its year-end guidance for

Gainers InMed Pharmaceuticals (NASDAQ:INM) stock moved upwards by 66.8% to $2.57 during Wednesday&#

Updated Clinical Data in PCNSL Increased Guidance on Year-End Data in CLL Company to Host Webcast at

Gainers: Q32 Bio up 29.6%, Mint up 75.8%, Fast Track up 58.2%, eLong up 33.4%, Sobr Safe up 29.2%, E

On June 26, 2026, Curis announced that eleven clinical sites had opened for enrollment in the TakeAi

LEXINGTON, Mass., July 6, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company f

Curis, Inc. shares surged 8.51% after the bell after the company confirmed its approved reverse stoc

Gainers Curis (NASDAQ:CRIS) stock rose 9.0% to $0.46 during Wednesday's after-market session. T

Gainers Can Fite Biopharma (AMEX:CANF) shares rose 43.8% to $4.27 during Wednesday's regular se

Universe Pharmaceuticals Inc (NASDAQ: UPC) surged 228.4% to $9.72 in pre-market trading after announ

Gainers INVO Fertility (NASDAQ:IVF) shares moved upwards by 67.3% to $2.08 during Friday's regu

Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance

Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development of emavusertib (CA-494

Eleven sites open for patient enrollment in TakeAim CLL combination study with zanubrutinib; Company

Gainers Atlantic International (NASDAQ:ATLN) shares increased by 41.0% to $1.1 during Thursday'

Curis, Inc. (CRIS) Q1 2026 Earnings Call Transcript

Curis (NASDAQ:CRIS) reported quarterly losses of $(1.25) per share which missed the analyst consensu

Curis (NASDAQ:CRIS) reported quarterly losses of $(1.25) per share which missed the analyst consensu

Management to host conference call today at 4:30 p.m. ET LEXINGTON, Mass.

LEXINGTON, Mass., May 5, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company fo

Kiniksa Pharmaceuticals International, plc (KNSA) came out with quarterly earnings of $0.27 per shar

Curis (CRIS) might move higher on growing optimism about its earnings prospects, which is reflected

Curis, Inc. (CRIS) Q4 2025 Earnings Call Transcript

Curis (NASDAQ:CRIS) reported quarterly losses of $(0.50) per share which missed the analyst consensu

Curis (NASDAQ:CRIS) reported quarterly losses of $(1.23) per share which missed the analyst consensu

Management to host conference call today at 4:30 p.m. ET LEXINGTON, Mass.

INGOLSTADT, Germany--(BUSINESS WIRE)--SecurityBridge, a leading provider of cybersecurity solutions

LEXINGTON, Mass., March 12, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company

eXoZymes (NASDAQ: EXOZ - Get Free Report) and Curis (NASDAQ: CRIS - Get Free Report) are both small-

Led by Nantahala Capital, Stonepine Capital Management, Pointillist Partners, LLC, and The Red Hook

LEXINGTON, Mass., Jan. 7, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company f

Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly e

Gainers Harbor Custom Development, Inc. (NASDAQ: HCDI) rose 74.2% to $1.50 after surging 24% on Th